Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...

Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...

AMSTERDAM -- A cardiac resynchronization therapy (CRT) upgrade produced solid clinical benefit for patients with pacing-induced heart failure with reduced ejection fraction (HFrEF), the small BUDAPEST ...

Amsterdam, Netherlands – 26 Aug 2023: Upgrade to cardiac resynchronisation therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodelling ...

It's dangerous in medicine to make decisions based solely on what makes intuitive sense. At the European Society of Cardiology (ESC) Congress 2023, we learned from the BUDAPEST CRT trial that the ...

“St. Jude Medical is the leader in quadripolar pacing technology, provided in our high voltage CRT-D devices since 2009. In International markets where the Allure Quadra CRT pacemaker is available, we ...

CHICAGO, Nov 14 (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that ...

Please provide your email address to receive an email when new articles are posted on . Medtronic recalled ICDs and CRT-Ds with a glassed feedthrough made after Oct. 13, 2017 due to risk for low- or ...

Please provide your email address to receive an email when new articles are posted on . Among patients with nonischemic cardiomyopathy, women were less likely to die or have a ventricular event than ...

Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective. As described in a June notice made ...

(HealthDay News) — There is a lower risk of one-year ventricular arrhythmias or death in women with nonischemic cardiomyopathy and an implantable cardioverter defibrillator (ICD) compared with men, ...